Literature DB >> 27069543

Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells.

Jun Dou1, Yaoyao Ni1, Xiangfeng He2, Di Wu1, Miao Li1, Songyan Wu1, Rong Zhang1, Mei Guo1, Fengsu Zhao1.   

Abstract

Research on the relationship between aberrant long non-coding RNA (lncRNA) and cancer stem cell (CSC) biology in cancer patients has been recently gaining attention. The goal of this study was to investigate whether the decreasing lncRNA HOTAIR expression would inhibit human colorectal cancer (CRC) stem cells. CD133(+)CSCs were isolated from human CRC LoVo cell line by using a magnetic-activated cell sorting system, and were transfected with the expression vector-based small hairpin RNA targeting HOTAIR (shHOTAIR). The ability of cellular proliferation, migration, invasion, colony-forming, and the epithelial-mesenchymal transition (EMT)-associated molecule expression as well as the tumorigenicity of CD133(+)-shHOTAIR were evaluated by the MTT, wound-healing, cellular invasion, colony formation and Western blot assays, respectively. This study found that, when compared with control cells in vitro, CD133(+)-shHOTAIR exhibited the decreased HOTAIR expression, suppressed cellular proliferation, migration, invasion, colony-forming, and inhibited the Vimentin expression with increased E-cadherin expression. In particular, the down-regulation of the HOTAIR expression in CD133(+)CSCs markedly attenuated the tumor growth and lung metastasis in xenograft nude mice. Taken together, this study found that down-regulating the HOTAIR expression in CD133(+)CSCs could serve as a potential anti-cancer regimen to inhibit the invasiveness and metastasis of CRC CSCs.

Entities:  

Keywords:  Human colorectal cancer; RNA interference; cancer stem cells; epithelial-mesenchymal transition; lincRNA HOTAIR

Year:  2016        PMID: 27069543      PMCID: PMC4759419     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  39 in total

1.  High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.

Authors:  Maria Ausiliatrice Puglisi; Carlo Cenciarelli; Valentina Tesori; Marianna Cappellari; Maurizio Martini; Angela Maria Di Francesco; Ezio Giorda; Rita Carsetti; Lucia Ricci-Vitiani; Antonio Gasbarrini
Journal:  J Pathol       Date:  2015-05-12       Impact factor: 7.996

2.  Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines.

Authors:  Cleidson Pádua Alves; Aline Simoneti Fonseca; Bruna Rodrigues Muys; Rafaela de Barros E Lima Bueno; Matheus Carvalho Bürger; Jorge E S de Souza; Valeria Valente; Marco Antonio Zago; Wilson Araújo Silva
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

3.  Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.

Authors:  Juntao Lang; Xiaoli Lan; Yu Liu; Xueyan Jin; Tao Wu; Xun Sun; Qiong Wen; Rui An
Journal:  Nucl Med Biol       Date:  2015-01-09       Impact factor: 2.408

Review 4.  Long noncoding RNAs: functional surprises from the RNA world.

Authors:  Jeremy E Wilusz; Hongjae Sunwoo; David L Spector
Journal:  Genes Dev       Date:  2009-07-01       Impact factor: 11.361

5.  Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse.

Authors:  Xiangfeng He; Jing Wang; Fengshu Zhao; Fangliu Yu; Dengyu Chen; Kai Cai; Cuiping Yang; Junsong Chen; Jun Dou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

6.  Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma.

Authors:  Masahisa Ishibashi; Ryunosuke Kogo; Kohei Shibata; Genta Sawada; Yusuke Takahashi; Junji Kurashige; Sayuri Akiyoshi; Shin Sasaki; Takeshi Iwaya; Tomoya Sudo; Keishi Sugimachi; Koshi Mimori; Go Wakabayashi; Masaki Mori
Journal:  Oncol Rep       Date:  2012-12-28       Impact factor: 3.906

7.  Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.

Authors:  Jun Dou; Cuilian Jiang; Jing Wang; Xian Zhang; Fengshu Zhao; Weihua Hu; Xiangfeng He; Xiaoli Li; Dandan Zou; Ning Gu
Journal:  Cell Biol Int       Date:  2011-03       Impact factor: 3.612

8.  Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome.

Authors:  Lijing Luo; Jianfang Zeng; Bing Liang; Zhe Zhao; Lulu Sun; Dongyan Cao; Jiaxin Yang; Keng Shen
Journal:  Exp Mol Pathol       Date:  2011-07-20       Impact factor: 3.362

9.  Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1.

Authors:  Guang Yang; Shenghong Zhang; Fei Gao; Zhenyin Liu; Mingjian Lu; Sheng Peng; Tao Zhang; Fujun Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-02

10.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

View more
  38 in total

Review 1.  The emerging role of lncRNAs in the regulation of cancer stem cells.

Authors:  Rosario Castro-Oropeza; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Cell Oncol (Dordr)       Date:  2018-09-14       Impact factor: 6.730

2.  LncRNA LINC00473 promoted colorectal cancer cell proliferation and invasion by targeting miR-195 expression.

Authors:  Shilei Li; Chunyu Lv; Jun Li; Tao Xie; Xianbin Liu; Zhiwei Zheng; Zhaoyang Qin; Xizeng Hui; Yang Yu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.

Authors:  Kai Lin; Hong Jiang; Ling-Ling Zhang; Yi Jiang; Yu-Xian Yang; Guo-Dong Qiu; Yu-Qi She; Jie-Ting Zheng; Chen Chen; Ling Fang; Shu-Yao Zhang
Journal:  Dig Dis Sci       Date:  2018-05-28       Impact factor: 3.199

Review 4.  Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.

Authors:  Xue Lei; Qinglian He; Ziqi Li; Qian Zou; Pingrong Xu; Haibing Yu; Yuanlin Ding; Wei Zhu
Journal:  Med Oncol       Date:  2021-03-18       Impact factor: 3.064

5.  The central role of HOTAIR in the malignancy of CD44+ human hypopharyngeal carcinoma cells.

Authors:  Hongxia Cheng; Xinhua Cui; Ying Guo; Lintao Gu; Yaning Wang; Qirong Wang; Hui Liang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

6.  Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.

Authors:  Yong Yang; Hong Yang; Miao Xu; Haibin Zhang; Mingtao Sun; Peng Mu; Tongbao Dong; Shanmei Du; Kui Liu
Journal:  Hum Cell       Date:  2018-04-20       Impact factor: 4.174

7.  PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells.

Authors:  Miao Li; Fangfang Shi; Xiong Fei; Songyan Wu; Di Wu; Meng Pan; Shouhua Luo; Ning Gu; Jun Dou
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

8.  HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells.

Authors:  Meng Xue; Lu-Yi Chen; Wei-Jia Wang; Ting-Ting Su; Liu-Hong Shi; Lan Wang; Wen Zhang; Jian-Min Si; Liang-Jing Wang; Shu-Jie Chen
Journal:  Gastric Cancer       Date:  2018-02-07       Impact factor: 7.370

9.  HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.

Authors:  Jia Chen; Shu-Fen Hou; Feng-Jie Tang; Dai-Song Liu; Zi-Zi Chen; Hong-Lian Zhang; Shao-Hua Wang
Journal:  Oncogene       Date:  2021-10-25       Impact factor: 9.867

10.  HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.

Authors:  Ye Huang; Liang Wang; Di Liu
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.